These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27281081)

  • 21. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.
    Olfson M; Blanco C; Liu L; Moreno C; Laje G
    Arch Gen Psychiatry; 2006 Jun; 63(6):679-85. PubMed ID: 16754841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004.
    Aparasu RR; Bhatara V
    Curr Med Res Opin; 2007 Jan; 23(1):49-56. PubMed ID: 17257465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the risk of type 2 diabetes mellitus among children and adolescents with psychiatric disorders treated with atypical antipsychotics: a population-based nested case-control study.
    Lee H; Song DH; Kwon JW; Han E; Chang MJ; Kang HY
    Eur Child Adolesc Psychiatry; 2018 Oct; 27(10):1321-1334. PubMed ID: 29460164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cost-effectiveness analysis of off-label atypical antipsychotic treatment in children and adolescents with ADHD who have failed stimulant therapy.
    Sohn M; Talbert J; Moga DC; Blumenschein K
    Atten Defic Hyperact Disord; 2016 Sep; 8(3):149-58. PubMed ID: 27143026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
    Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
    Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical antipsychotic use among Medicaid-insured children and adolescents: duration, safety, and monitoring implications.
    Burcu M; Zito JM; Ibe A; Safer DJ
    J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):112-9. PubMed ID: 24690011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent mental health therapy among medicaid-enrolled youths starting antipsychotic medications.
    Harris E; Sorbero M; Kogan JN; Schuster J; Stein BD
    Psychiatr Serv; 2012 Apr; 63(4):351-6. PubMed ID: 22337007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004.
    Sankaranarayanan J; Puumala SE
    Curr Med Res Opin; 2007 Jun; 23(6):1375-85. PubMed ID: 17594776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in the use of typical and atypical antipsychotics in children and adolescents.
    Patel NC; Crismon ML; Hoagwood K; Johnsrud MT; Rascati KL; Wilson JP; Jensen PS
    J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):548-56. PubMed ID: 15908837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in the prescribing of atypical antipsychotics in elderly patients with dementia in Korea
.
    Seo N; Song I; Park H; Ha D; Shin JY
    Int J Clin Pharmacol Ther; 2017 Jul; 55(7):581-587. PubMed ID: 28372635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National trends in pediatric use of anticonvulsants.
    Tran AR; Zito JM; Safer DJ; Hundley SD
    Psychiatr Serv; 2012 Nov; 63(11):1095-101. PubMed ID: 22983637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of age on the profile of psychotropic users: results from the 2010 National Ambulatory Medical Care Survey.
    Maust DT; Oslin DW; Marcus SC
    J Am Geriatr Soc; 2014 Feb; 62(2):358-64. PubMed ID: 24417590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotic drug use among elderly nursing home residents in the United States.
    Kamble P; Chen H; Sherer J; Aparasu RR
    Am J Geriatr Pharmacother; 2008 Oct; 6(4):187-97. PubMed ID: 19028374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends and factors in antipsychotic use of outpatients with anxiety disorders in Taiwan, 2005-2013: A population-based study.
    Huang CW; Chiu YW; Chen PJ; Yu NW; Tsai HJ; Chang CM
    Psychiatry Clin Neurosci; 2019 Aug; 73(8):501-507. PubMed ID: 31077503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Unlicensed and Off-Label Use of Antipsychotics Prescribed to Child and Adolescent Psychiatric Outpatients for Treatment of Mental and Behavioral Disorders with Different Guidelines: The China Food and Drug Administration Versus the FDA.
    Zhu X; Hu J; Sun B; Deng S; Wen Y; Chen W; Qiu C; Shang D; Zhang M
    J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):216-224. PubMed ID: 29336603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric Off-label Antipsychotic Use for Attention-Deficit/Hyperactivity Disorder.
    Lee H; Zhang C; Rose R; dosReis S
    Clin Ther; 2022 Sep; 44(9):e83-e90. PubMed ID: 35965110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attention-Deficit/Hyperactivity Disorder and Psychotropic Polypharmacy Prescribing Trends.
    Girand HL; Litkowiec S; Sohn M
    Pediatrics; 2020 Jul; 146(1):. PubMed ID: 32487590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Off-label use of atypical antipsychotics: cause for concern?
    McKean A; Monasterio E
    CNS Drugs; 2012 May; 26(5):383-90. PubMed ID: 22448598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ten years of antipsychotic prescribing to children: a Canadian population-based study.
    Alessi-Severini S; Biscontri RG; Collins DM; Sareen J; Enns MW
    Can J Psychiatry; 2012 Jan; 57(1):52-8. PubMed ID: 22296959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of atypical antipsychotics in French psychiatric hospitals.
    Bret MC; Bret P; Pariente A; Fourier-Réglat A
    Pharm World Sci; 2007 Oct; 29(5):551-6. PubMed ID: 17638111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.